Načítá se...
Resiquimod enhances mucosal and systemic immunity against avian infectious bronchitis virus vaccine in the chicken
Adjuvant enhancing mucosal immune response is preferred in controlling many pathogens at the portal of entry. Earlier, we reported that a toll-like-receptor 7 (TLR7) agonist, resiquimod (R-848), stimulated the systemic immunity when adjuvanted with the inactivated Newcastle disease virus vaccine in...
Uloženo v:
| Vydáno v: | Microb Pathog |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier Ltd.
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7127065/ https://ncbi.nlm.nih.gov/pubmed/29635053 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.micpath.2018.04.012 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|